Abilify Wins FDA Approval

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Company won FDA approval for Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.

 

close

Next Article in Channel